订阅小程序
旧版功能

Long-Term Outcomes of a Phase I Study with UV1, a Second Generation Telomerase Based Vaccine, in Patients with Advanced Non-Small Cell Lung Cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2019)

引用 26|浏览5
关键词
non-small cell lung cancer,human telomerase reverse transcriptase,peptide,vaccine monotherapy,dose response,clinical efficacy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要